Detection of Phospho-KRAS by Electrophoretic Mobility Change in Human Cell Lines and in Tumor Samples from Nude Mice Grafts (original) (raw)

Profiling oncogenic KRAS mutant drugs with a cell-based Lumit p-ERK immunoassay

Said Goueli

SLAS Discovery, 2022

View PDFchevron_right

KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas

Leticia Miravalle

Histopathology, 2012

View PDFchevron_right

Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

luis raez

Molecular Cancer Therapeutics, 2021

View PDFchevron_right

Kras g12d in colon cancer

Alberto Zaniboni

View PDFchevron_right

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer

Chiara Caparello

Scientific Reports, 2017

View PDFchevron_right

The Role of KRAS in Endometrial Cancer: A Mini-Review

Savvas Papagrigoriadis

Anticancer Research, 2019

View PDFchevron_right

Clinical Relevance of KRAS in Human Cancers

Jiri Drabek

Journal of Biomedicine and Biotechnology, 2010

View PDFchevron_right

HTRF® Total and Phospho-YAP (Ser127) Cellular Assays

merve bilgiç

Methods in Molecular Biology, 2018

View PDFchevron_right

Tumor Growth Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for

Noelia Paco

2014

View PDFchevron_right

IJSRST1845222 | Molecular Characterization of human KRAS protein using Bioinformatics tools

Smita Kashetti

View PDFchevron_right

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma

Anne Casanova

Lung Cancer, 2016

View PDFchevron_right

Lymphocyte Electrotaxis In Vitro and In Vivo

Juan Santiago

The Journal of Immunology, 2008

View PDFchevron_right

KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer

Savvas Papagrigoriadis

Anticancer Research, 2017

View PDFchevron_right

Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth

Neus Agell

Cancer Research, 2014

View PDFchevron_right

Cell-Based Assays Move to Fore

Josh Roberts

Genetic Engineering & Biotechnology News, 2011

View PDFchevron_right

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy

Elin Richardsen

The Journal of Pathology: Clinical Research, 2021

View PDFchevron_right

Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides

Caroline Van Kim

British Journal of Haematology, 1997

View PDFchevron_right

Flow cytometric study of cultured mammalian cells

Mohamed al-Rubeai

Journal of Biotechnology, 1991

View PDFchevron_right

Phosphatases: The New Brakes for Cancer Development?

Francois Claret

Enzyme Research, 2012

View PDFchevron_right

KRAS-specific antibody binds to KRAS protein inside colorectal adenocarcinoma cells and inhibits its localization to the plasma membrane

Emile Tan

Frontiers in Oncology, 2023

View PDFchevron_right

Knock-in of oncogenic KRAS does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers

Sabrina Arena

2007

View PDFchevron_right

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

Simona Lamba

International Journal of Cancer, 2013

View PDFchevron_right

KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice

Denny Schanze

JCI Insight

View PDFchevron_right

Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

Xingdi Ma

Cancer Discovery, 2020

View PDFchevron_right

Co-regulation of metastatic and transforming activity of normal and mutantras genes

Sean Egan

International Journal of Cancer, 1989

View PDFchevron_right

Oncogenic Kras Requires Simultaneous PI3K Signaling to Induce ERK Activation and Transform Thyroid Epithelial Cells In vivo

Xiao Hui Liao

Cancer Research, 2009

View PDFchevron_right

A suggested mechanism for changing tumor cell phenotype: Transfection of host cells with DNA sequences of dead tumor cells

Benjamin Klein

Medical Hypotheses, 1981

View PDFchevron_right

A Rapid Screening Assay to Search for Phosphorylated Proteins in Tissue Extracts

Ignazio Garaguso

PLoS ONE, 2012

View PDFchevron_right

Electrochemical treatment of tumours

Peter Wersäll

Bioelectrochemistry, 2000

View PDFchevron_right

Ikaros, CK2 kinase, and the road to leukemia

Chunhua Song

Molecular and Cellular Biochemistry, 2011

View PDFchevron_right

Spatial proteomic and phospho-proteomic organization in three prototypical cell migration modes

Alexander Schmidt

Proteome Science, 2014

View PDFchevron_right

A high-throughput assay for the detection of Tyr-phosphorylated proteins in urine of bladder cancer patients

Antonella Pantaleo

Biochimica et Biophysica Acta (BBA) - General Subjects, 2013

View PDFchevron_right

Inwardly rectifying whole cell potassium current in human blood eosinophils

Dmitri Gordienko

The Journal of Physiology, 1998

View PDFchevron_right

Molecular Characterization of human KRAS protein using Bioinformatics tools

International Journal of Scientific Research in Science and Technology IJSRST

View PDFchevron_right

Whole-Organism Cellular Pathology

Keith Cheng

Advances in Genetics, 2016

View PDFchevron_right